SABR for NCSLC
rule

SABR for NSCLC: From an Alternative to Conventional Radiotherapy to an Alternative for Surgery

A session from the 2015 Radiosurgery Society Webinar Series as presented by:

  • Ben Slotman, MD, PhD, Professor Radiation Oncology, Vrije Universiteit Medical Center (VUmc), Amsterdam, The Netherlands
This course is available to physicians from November 16, 2015, through 11:59 p.m. Eastern time on December 31, 2021.
 
This course is available to medical physicists from April 1, 2016, through 11:59 p.m. Eastern Time on April 1, 2019.

In order to earn credit for this course, participants must:

    • View the audio/slide presentation
    • Pass the five-question examination with a minimum of 70%, and
    • Complete the course evaluation.

The activity is approximately 1 hour in length.

Course Fees

  • Non-Member: $25.00
  • RSS Member: Free 
    • Login to find your discount code. It is on the member resources page.


Statement of Need

Stereotactic ablative radiotherapy has replaced conventionally fractionated radiotherapy in medically inoperable patients with early stage lung cancer, The high local control rates and improved survival have led to studies investigating SABR as an alternative to surgery. A number of randomized trials comparing SABR and surgery have failed to accrue enough patients.

In this webinar, the use and outcomes of SABR for peripheral and central tumors in patients with medically inoperable early stage NSCLC will be discussed. In addition, the potential role of SABR as an alternative to surgery for operable patients will be addressed.

Target Audience

This program is designed to meet the needs of radiation oncologists with interests in SABR for the treatment of inoperable early stage NSCLC.


Activity Objectives

  • Describe the role of SABR for medically inoperable early stage Non-Small Cell Lung Cancer (NSCLC)
  • Describe the role of SABR in central tumors
  • Explain the most common toxicities of SABR
  • Discuss the principles of treatment planning to deliver SBRT to pancreatic and liver tumors
  • Understand the role of SABR in operable patients


Disclosure

It is the policy of the Minnesota Medical Association (MMA) to ensure balance, independence, objectivity, and scientific rigor in its CME activities. To comply with the Standards for Commercial Support of the Accreditation Council for Continuing Medical Education (ACCME), the MMA requires planning committee members and faculty to disclose any relevant financial relationship he/she and his/her spouse/partner has with a commercial interest.

CME Statement

The Minnesota Medical Association designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This SAM has been qualified by the American Board of Radiology (ABR) in meeting the criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification Program on October 30, 2015.

Certificate of Participation

A certificate will be issued upon completion of course requirements, including the evaluation, enabling you to register your credit with the appropriate licensing boards or associations.

Continuing Education (CE) Availability for Physicists

The Radiosurgery Society Self-Assessment Module (SAM) titled SABR for NSCLC: From an Alternative to Conventional Radiotherapy to an Alternative for Surgery is qualified by the American Board of Radiology (ABR) in meeting the criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification Program. This MP SAM is "Qualified by the American Board of Radiology in meeting the criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification Program and has qualified for 1 SAM credit." The ABR qualified this MP SAM on March 11, 2016.



Technology Requirements

Software Requirements

  • A browser version of Internet Explorer 10.0 and higher or Firefox 3.0 or higher, Google Chrome Version 35 or higher.

A note on browser incompatibility:

  • We have tested IE 6.x in controlled configurations and we can stream successfully, but there are some versions that may not support the RTMP streams we push out - basically new technology that old technology can't handle.
  • Possible remedy: upgrade browser version, try alternate browsers such as Firefox.
  • Flash Player Version 11 or higher. If you have an older version, it would be best to upgrade now. It's free and does not require a reboot. http://get.adobe.com/flashplayer/

Hardware Requirements

  • Windows Based Computer, Mac based Computers, smart phone, tablets
  • Windows XP SP 3 or Vista Home Premium or better
  • Mac OS x 10.5.3 or better
  • Pentium 4 or better
  • 1meg of System Ram (Memory)
  • True Color 32 bit video card
  • Sound card and speakers
For more help with technical issues please click here.



Policies

No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed on the RSS website under the title of the course.

Participants using RSS online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.

The course and its materials will only be available on the RSS website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. The RSS reserves the right to remove a course before the end of its qualification period.

Please contact admin@therss.org if you have questions.

Member login  
rule











Like our Facebook Page   
Join our Facebook Group
Follow us on Twitter 
Follow our Group on LinkedIn
Visit our Journal on Cureus

Journal of Neuro-Oncology
Join our Mailing List
divider